Literature DB >> 20173274

Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse.

John D Piette1, Michele Heisler, Anita Harand, Michelina Juip.   

Abstract

OBJECTIVES: This study sought to understand differences across racial groups in diabetes patients' medication-related beliefs and adherence problems due to cost concerns. RESEARCH DESIGN AND METHODS: We surveyed 806 African American and White diabetes patients about their beliefs regarding medications, cost-related adherence problems, socioeconomic status and communication about treatments with their clinicians.
RESULTS: Many patients endorsed statements such as "Most prescription medications are addictive" (35%) and "Insurance plans push generics to save themselves money at the expense of my health" (65%). African Americans expressed more negative attitudes than White patients and were more likely than White patients to report cost-related medication underuse (19% versus 13%; p5.02). Medication-related attitudes did not explain the higher rates of cost-related medication underuse among Black patients.
CONCLUSIONS: Many diabetes patients have negative beliefs about their medications. Other unknown factors however, explain higher rates of cost-related adherence problems among African American compared with White patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173274     DOI: 10.1353/hpu.0.0247

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  25 in total

1.  The RxHL study: community-responsive research to explore barriers to medication adherence.

Authors:  Susan J Shaw; Josephine D Korchmaros; Cristina Huebner Torres; Molly S Totman; Jeannie K Lee
Journal:  Health Educ Res       Date:  2019-12-01

2.  The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes.

Authors:  Quyen Ngo-Metzger; Dara H Sorkin; John Billimek; Sheldon Greenfield; Sherrie H Kaplan
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

3.  Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.

Authors:  Robert J Romanelli; Jodi B Segal
Journal:  J Gen Intern Med       Date:  2014-06-24       Impact factor: 5.128

4.  Determinants of Generic Drug Substitution in the United States.

Authors:  Jodi B Segal; Oluwadamilola Onasanya; Matthew Daubresse; Chia-Ying Lee; Mischka Moechtar; Xia Pu; Sarah K Dutcher; Robert J Romanelli
Journal:  Ther Innov Regul Sci       Date:  2020-01-06       Impact factor: 1.778

5.  Perception of generic prescription drugs and utilization of generic drug discount programs.

Authors:  Anthony Omojasola; Mike Hernandez; Sujit Sansgiry; Lovell Jones
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

6.  The MEssaging for Diabetes Intervention Reduced Barriers to Medication Adherence Among Low-Income, Diverse Adults With Type 2.

Authors:  Lindsay S Mayberry; Shelagh A Mulvaney; Kevin B Johnson; Chandra Y Osborn
Journal:  J Diabetes Sci Technol       Date:  2016-09-25

7.  Diabetes: Christian worldview, medical distrust and self-management.

Authors:  Kelley Newlin Lew; Nancy Arbauh; Paul Banach; Gail Melkus
Journal:  J Relig Health       Date:  2015-06

8.  Patient Perceptions of Deprescribing: Survey Development and Psychometric Assessment.

Authors:  Amy Linsky; Steven R Simon; Kelly Stolzmann; Mark Meterko
Journal:  Med Care       Date:  2017-03       Impact factor: 2.983

9.  Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis.

Authors:  S Silverman; A Calderon; K Kaw; T B Childers; B A Stafford; W Brynildsen; A Focil; M Koenig; D T Gold
Journal:  Osteoporos Int       Date:  2012-12-18       Impact factor: 4.507

Review 10.  Self-Care Disparities Among Adults with Type 2 Diabetes in the USA.

Authors:  Lindsay Satterwhite Mayberry; Erin M Bergner; Rosette J Chakkalakal; Tom A Elasy; Chandra Y Osborn
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.